We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+30.69%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$5.45B
AUM Growth
+$454M
(+9.1%)
Cap. Flow
-$312M
Cap. Flow
% of AUM
-5.73%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
130
New
20
Increased
22
Reduced
29
Closed
17
Top Buys
| 1 |
ArriVent BioPharma
AVBP
|
+$61.1M |
| 2 |
Cytokinetics
CYTK
|
+$52.8M |
| 3 |
Esperion Therapeutics
ESPR
|
+$33.3M |
| 4 |
Merck
MRK
|
+$32.2M |
| 5 |
Q32 Bio
QTTB
|
+$31M |
Top Sells
| 1 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
+$147M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$93.5M |
| 3 |
United Therapeutics
UTHR
|
+$84.9M |
| 4 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
+$71.7M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$69.9M |
Sector Composition
| 1 | Healthcare | 99.34% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Invivyd
IVVD
$241M
| $11.9M | 0.22% |
2,690,300
-1,437,265
| -35% | -$5.94M |
|
77
PMV Pharmaceuticals
PMVP
$74.7M
| $11M | 0.2% |
6,475,291
| – | – |
|
|
VTYX
78
DELISTED
Ventyx Biosciences
VTYX
| $10.3M | 0.19% |
+1,870,456
| New | +$8.55M |
|
79
Fate Therapeutics
FATE
$349M
| $9.95M | 0.18% |
1,355,352
+827,272
| +157% | +$5.12M |
|
80
X4 Pharmaceuticals
XFOR
$368M
| $9.92M | 0.18% |
237,784
| – | – |
|
|
EXAS
81
DELISTED
Exact Sciences
EXAS
| $9.7M | 0.18% |
+140,400
| New | +$8.88M |
|
82
Cullinan Oncology
CGEM
$1.1B
| $8.82M | 0.16% |
517,606
-27,242
| -5% | -$421K |
|
83
Nkarta
NKTX
$190M
| $8.65M | 0.16% |
+800,000
| New | +$8.32M |
|
84
Lexicon Pharmaceuticals
LXRX
$977M
| $8.5M | 0.16% |
+3,542,000
| New | +$7.61M |
|
85
10x Genomics
TXG
$5.81B
| $8.45M | 0.16% |
225,200
+185,400
| +466% | +$8.15M |
|
|
TSBX
86
DELISTED
Turnstone Biologics
TSBX
| $8.12M | 0.15% |
3,099,265
| – | – |
|
87
Perspective Therapeutics
CATX
$367M
| $7.74M | 0.14% |
+650,580
| New | +$5.55M |
|
88
CytomX Therapeutics
CTMX
$801M
| $7.73M | 0.14% |
+3,544,578
| New | +$6.54M |
|
|
FOLD
89
DELISTED
Amicus Therapeutics
FOLD
| $6.72M | 0.12% |
570,300
-235,700
| -29% | -$3.01M |
|
90
Krystal Biotech
KRYS
$10.3B
| $6.61M | 0.12% |
37,166
-66,534
| -64% | -$9.24M |
|
91
Vir Biotechnology
VIR
$1.62B
| $6.48M | 0.12% |
640,000
+539,000
| +534% | +$5.49M |
|
92
Apollomics
APLM
$42.1M
| $6.42M | 0.12% |
85,655
| – | – |
|
93
InspireMD
NSPR
$33.7M
| $5.06M | 0.09% |
2,133,405
| – | – |
|
|
IMA
94
ImageneBio Inc
IMA
$67.8M
| $5.03M | 0.09% |
294,947
| – | – |
|
|
ELEV
95
DELISTED
Elevation Oncology
ELEV
| $4.83M | 0.09% |
941,275
-558,725
| -37% | -$1.81M |
|
96
Progyny
PGNY
$2.53B
| $4.32M | 0.08% |
+113,300
| New | +$4.28M |
|
97
Oric Pharmaceuticals
ORIC
$1.15B
| $3.95M | 0.07% |
287,100
-235,868
| -45% | -$2.8M |
|
98
Milestone Pharmaceuticals
MIST
$158M
| $3.58M | 0.07% |
+2,000,000
| New | +$3.25M |
|
99
NextCure
NXTC
$27M
| $2.54M | 0.05% |
95,100
-130,818
| -58% | -$2.25M |
|
100
Bolt Biotherapeutics
BOLT
$8.09M
| $2.16M | 0.04% |
77,050
| – | – |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM